ADRD Induced pluripotent stem cell/organoid core
ADRD Induced pluripotent stem cell/organoid core
批准号:
10647771
负责人:
Lisa M Ellerby
金额:
$33.98万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-30 至 2026-05-31
关键词:
AddressAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAstrocytesBrainCell AgingCell CommunicationCell Culture TechniquesCell LineCell modelCellsCerebrumCoculture TechniquesDementiaDiseaseDisease ProgressionElectrophysiology (science)EnsureEquipmentEthicsFreezingFrontotemporal DementiaGoalsHumanImageInduced pluripotent stem cell derived neuronsInfrastructureInterventionKnowledgeMaintenanceMeasurementMicrogliaModelingMusMycoplasmaNeuronsOnset of illnessOrganizational ObjectivesOrganoidsParticipantPathway interactionsPatientsPostdoctoral FellowQuarantineReproducibilityResearchResearch PersonnelRoleScientistServicesSourceSpecificityTechnologyTestingTrainingValidationage relatedage related neurodegenerationcell typecellular imagingcombatexperienceinduced pluripotent stem cellmouse modelprogramssenescencestem cell modelstudent trainingtau mutation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The goals of the Program Project are to understand the causes and consequences of cellular senescence as a
driver of age-related neurodegeneration, determine new targets and mechanisms by which senescent cells drive
disease, and identify new targets for interventions that alter disease onset and/or progression. The Alzheimer’s
disease and related dementias (ADRD) induced pluripotent stem cell (iPSC)/organoid core, led by Drs.
Ellerby and Tracy, will provide expertise in generating iPSC-derived neurons, astrocytes, microglia, co-cultures
and brain organoids to understand cellular senescence as a driver of age-related neurodegeneration. It will
provide a suite of iPSC cellular models to all three projects and validate all the derived cell types, co-cultures
and brain organoids. The Core will provide essential infrastructure, training and support for all scientists
participating in the PPG. In addition, it will provide everything needed to culture, conduct electrophysiological
recordings, and image cells. The Core directors have experience in all of these cell manipulations and will
approve all Alzheimer’s-related disease (ARD) and control iPSC models for the facility, including live and frozen
cell cultures from commercial and academic sources, to ensure reproducibility, authentication, testing for
mycoplasma, and other cell line maintenance and validation tasks. These Core directors will approve all
Alzheimer’s disease related and control iPSC models for the facility, including live and frozen cell cultures from
commercial and academic sources, to ensure reproducibility, authentication, testing for mycoplasma, and other
cell line maintenance and validation tasks. The Core will train students and postdoctoral fellows and oversee
any research involving iPSCs that require ESCRO approvals, ethics training and MTAs. To accomplish these
goals, five specific aims of the ‘ADRD iPSC/Organoid Core’ are described. These goals are organized around
the cell type or technology that is needed to address the research questions described in the three projects in
an efficient and optimized approach. The Specific Aims of this Core are: Specific Aim 1 – Generate a bank of
iPSCs derived from the indicated models; Specific Aim 2 – Microglia. Generate microglia from iPSCs derived
from the models (Projects 1, 2 and 3); Specific Aim 3 – Astrocytes. Generate astrocytes from iPSCs derived from
the models (Projects 1 and 3); Specific Aim 4 – Cortical Neurons. Generate cortical neurons (excitatory and
inhibitory) from iPSCs derived from the models (Projects 1, 2 and 3); Specific Aim 5 – Cerebral Organoids and
Co-cultures. Provide cerebral organoids (Projects 1 and 3); Specific Aim 6 – Electrophysiology and Imaging.
We will perform electrophysiological recordings for Projects 1, 2 and 3 in both human cellular models and mouse
models. These aims will provide models and technology that will enhance our knowledge of cell type specificity
and interactions in AD cellular senescence and identify new pathways and targets of opportunity to combat AD
and related dementias.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
-
批准号:10491094
-
项目类别:
-
资助金额:$52.05万
-
财政年份:2021
-
负责人:Lisa M Ellerby
-
依托单位:
ADRD Induced pluripotent stem cell/organoid core
-
批准号:10491068
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2021
-
负责人:Lisa M Ellerby
-
依托单位:
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias
-
批准号:10647768
-
项目类别:
-
资助金额:$287.84万
-
财政年份:2021
-
负责人:Lisa M Ellerby
-
依托单位:
Determining the role of OXR1 in aging and Alzheimer's disease
-
批准号:10461321
-
项目类别:
-
资助金额:$85.14万
-
财政年份:2021
-
负责人:Lisa M Ellerby
-
依托单位:
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
-
批准号:10647782
-
项目类别:
-
资助金额:$51.76万
-
财政年份:2021
-
负责人:Lisa M Ellerby
-
依托单位:
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
-
批准号:10187414
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2021
-
负责人:Lisa M Ellerby
-
依托单位:
ADRD Induced pluripotent stem cell/organoid core
-
批准号:10187409
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2021
-
负责人:Lisa M Ellerby
-
依托单位:
Evaluation of the role of RNA toxicity in SCA2 pathogenesis using genome editing in patient iPSCs
-
批准号:9803833
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2019
-
负责人:Lisa M Ellerby
-
依托单位:
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
-
批准号:9926800
-
项目类别:
-
资助金额:$87.96万
-
财政年份:2018
-
负责人:Lisa M Ellerby
-
依托单位:
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
-
批准号:10417069
-
项目类别:
-
资助金额:$87.96万
-
财政年份:2018
-
负责人:Lisa M Ellerby
-
依托单位:
Genetic Correction of Mutant Huntingtin in Vivo
-
批准号:10011868
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2016
-
负责人:Lisa M Ellerby
-
依托单位:
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells
-
批准号:9790987
-
项目类别:
-
资助金额:$61.61万
-
财政年份:2016
-
负责人:Lisa M Ellerby
-
依托单位:
Genetic Correction of Mutant Huntingtin in Vivo
-
批准号:9790981
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2016
-
负责人:Lisa M Ellerby
-
依托单位:
Genetic Correction of Mutant Huntingtin in Vivo
-
批准号:9247635
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2016
-
负责人:Lisa M Ellerby
-
依托单位:
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells
-
批准号:10011887
-
项目类别:
-
资助金额:$61.42万
-
财政年份:2016
-
负责人:Lisa M Ellerby
-
依托单位:
Comprehensive Synaptome Proteomics Targeting Protein Expression and PTMs in HD
-
批准号:9149037
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2015
-
负责人:Lisa M Ellerby
-
依托单位:
Matrix Metalloproteinases: Therapeutic Targets For Huntington's Disease
-
批准号:8927075
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2013
-
负责人:Lisa M Ellerby
-
依托单位:
Matrix Metalloproteinases: Therapeutic Targets For Huntington's Disease
-
批准号:8489062
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2013
-
负责人:Lisa M Ellerby
-
依托单位:
Matrix Metalloproteinases: Therapeutic Targets For Huntington's Disease
-
批准号:8739316
-
项目类别:
-
资助金额:$42.01万
-
财政年份:2013
-
负责人:Lisa M Ellerby
-
依托单位:
HDACs in Neurodegeneration and Aging
-
批准号:7878516
-
项目类别:
-
资助金额:$47.56万
-
财政年份:2007
-
负责人:Lisa M Ellerby
-
依托单位: